Early-onset late-life depression: Association with body mass index, obesity, and treatment response

被引:3
|
作者
Chae, Woo Ri [1 ,2 ,3 ,6 ]
Fuentes-Casan, Manuel [1 ,2 ,3 ]
Gutknecht, Felix [1 ,2 ,3 ]
Ljubez, Angela [1 ,2 ,3 ]
Gold, Stefan M. [1 ,2 ,3 ,4 ,5 ]
Wingenfeld, Katja [1 ,2 ,3 ]
Otte, Christian [1 ,2 ,3 ]
机构
[1] Charite Univ Med Berlin, Hindenburgdamm 30, D-12203 Berlin, Germany
[2] Humboldt Univ, Freie Univ Berlin, Hindenburgdamm 30, D-12203 Berlin, Germany
[3] Berlin Inst Hlth, Dept Psychiat & Psychotherapy, Campus Benjamin Franklin, Hindenburgdamm 30, D-12203 Berlin, Germany
[4] Berlin Inst Hlth, Ctr Internal Med & Dermatol, Dept Psychosomat Med, Hindenburgdamm 30, D-12203 Berlin, Germany
[5] Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & Multiple Sclerosis INIMS, Ctr Mol Neurobiol, Falkenried 94, D-20251 Hamburg, Germany
[6] Charite Univ Med Berlin, Dept Psychiat & Psychotherapy, Campus Benjamin Franklin, Hindenburgdamm 30, D-12203 Berlin, Germany
关键词
Depressive disorder; Late-life depression; Chart review; Obesity; Treatment outcome; WHITE-MATTER HYPERINTENSITIES; HIPPOCAMPAL VOLUMES; METABOLIC SYNDROME; DISEASE; METAANALYSIS; OVERWEIGHT; MORTALITY; ATROPHY; MRI; AGE;
D O I
10.1016/j.cpnec.2021.100096
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Early-onset (EOD) and late-onset (LOD) late-life depression might differ in etiology, clinical features, and treatment response. While EOD is more frequently associated with a family history of affective disorders and personality aspects, LOD is thought to be more strongly driven by acquired cerebrovascular risk factors associated with vascular pathology, executive dysfunction, and poor treatment response. However, in a systematic review, EOD and LOD only differed in the frequency of affective disorders in the family history. We compared EOD versus LOD using medical records. In this retrospective chart review, elderly depressed patients (N = 108; mean age: 69.0 +/- 7.2 years) were characterized by sociodemographic, psychiatric, and somatic variables and divided according to age-at-onset (cut-off: 60 years): EOD (N = 67, mean age-at-onset: 40.2 +/- 13.6 years) and LOD (N = 41, 67.5 +/- 6.3 years). A family history of affective disorders was more common in EOD than LOD patients (49.2% vs. 19.5%). EOD patients had a higher body mass index (mean: 27.0 kg/m2 vs. 23.1 kg/m2) and were more often obese compared with LOD patients (20% vs. 0%). There were fewer treatment responders in the EOD group than in the LOD group on trend level significance (46.3% vs. 63.4%). Higher frequency of affective disorders in the family history is compatible with a greater genetic risk of EOD. The larger metabolic burden of EOD might stem from the longer duration of depressive illness.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Pharmacological treatment of late-life depression
    Ignjatovic, D
    Ignjatovic, M
    EUROPEAN PSYCHIATRY, 2004, 19 : 211S - 211S
  • [42] Treatment strategy for late-life depression
    Baba, Hajime
    PSYCHIATRY AND CLINICAL NEUROSCIENCES REPORTS, 2023, 2 (02):
  • [43] Mechanisms and treatment of late-life depression
    Alexopoulos, George S.
    TRANSLATIONAL PSYCHIATRY, 2019, 9 (1)
  • [44] Pharmacological treatment of late-life depression
    Ignjatovic, D
    Ignjatovic, M
    Nutt, DJ
    PHARMACOPSYCHIATRY, 2005, 38 (01) : 53 - 54
  • [45] LATE-LIFE DEPRESSIVE DISORDER IN THE COMMUNITY, EARLY-ONSET AND THE DECREASE OF VULNERABILITY WITH INCREASING AGE
    VANOJEN, R
    HOOIJER, C
    JONKER, C
    LINDEBOOM, J
    VANTILBURG, W
    JOURNAL OF AFFECTIVE DISORDERS, 1995, 33 (03) : 159 - 166
  • [46] Late-Life Depression and Lewy Body Disease
    Fujishiro, Hiroshige
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2019, 27 (03): : 287 - 289
  • [47] A systematic review comparing clinical features in early age at onset and late age at onset late-life depression
    Grayson, Louise
    Thomas, Alan
    JOURNAL OF AFFECTIVE DISORDERS, 2013, 150 (02) : 161 - 170
  • [48] Allelic Variation in the Serotonin Transporter Promoter Affects Onset of Paroxetine Treatment Response in Late-Life Depression
    Bruce G Pollock
    Robert E Ferrell
    Benoit H Mulsant
    Sati Mazumdar
    Mark Miller
    Robert A Sweet
    Stephanie Davis
    Margaret A Kirshner
    Patricia R Houck
    Jacqueline A Stack
    Charles F Reynolds III
    David J Kupfer
    Neuropsychopharmacology, 2000, 23 : 587 - 590
  • [49] Allelic variation, in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression
    Pollock, BG
    Ferrell, RE
    Mulsant, BH
    Mazumdar, S
    Miller, M
    Sweet, RA
    Davis, S
    Kirshner, MA
    Houck, PR
    Stack, JA
    Reynolds, CF
    Kupfer, DJ
    NEUROPSYCHOPHARMACOLOGY, 2000, 23 (05) : 587 - 590
  • [50] The Importance of Mid-to-Late-Life Body Mass Index Trajectories on Late-Life Gait Speed
    Windham, B. Gwen
    Griswold, Michael E.
    Wang, Wanmei
    Kucharska-Newton, Anna
    Demerath, Ellen W.
    Gabriel, Kelley Pettee
    Pompeii, Lisa A.
    Butler, Kenneth
    Wagenknecht, Lynne
    Kritchevsky, Stephen
    Mosley, Thomas H., Jr.
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2017, 72 (08): : 1130 - 1136